BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7041599)

  • 1. Comparison of antihypertensive and hormonal effects of captopril and propranolol at rest and during exercise.
    Pickering TG; Case DB; Sullivan PA; Laragh JH
    Am J Cardiol; 1982 Apr; 49(6):1566-8. PubMed ID: 7041599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypotensive effect of propranolol in captopril-treated patients does not involve the plasma renin--angiotensin--aldosterone system.
    Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():441s-444s. PubMed ID: 7032826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of captopril and propranolol on the responses to posture and isometric exercise in patients with essential hypertension.
    Vandenburg MJ; Holly JM; Goodwin FJ; Sharman VL; Marsh FP
    Eur J Clin Pharmacol; 1983; 25(6):721-8. PubMed ID: 6319152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hypotensive and renin-stimulating actions of captopril before and during treatment with a beta-blocking drug.
    Leonetti G; Biachini C; Terzoli L; Gradnik R; Tusa M; Bramati E; Zanchetti A
    Am J Cardiol; 1982 Apr; 49(6):1564-5. PubMed ID: 6280485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients.
    Ogihara T; Maruyama A; Hata T; Mikami H; Nakamaru M; Naka T; Ohde H; Kumahara Y
    Clin Pharmacol Ther; 1981 Sep; 30(3):328-35. PubMed ID: 6268347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin system during converting enzyme inhibition with captopril in patients with severe treatment-resistant hypertension.
    Rasmussen S; Damkjaer Nielsen M; Ibsen H; Leth A; Giese J
    Eur J Clin Invest; 1984 Feb; 14(1):30-6. PubMed ID: 6321195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of captopril and propranolol, alone and in combination, on the responses to isometric and dynamic exercise in normotensive and hypertensive men.
    Ferguson RK; Vlasses PH; Koffer H; Clementi RA; Koplin JR; Willcox CM
    Pharmacotherapy; 1983; 3(2 Pt 1):125-30. PubMed ID: 6344035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind comparison between propranolol and bendroflumethiazide in captopril-treated resistant hypertensive patients.
    Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A
    Am Heart J; 1983 Aug; 106(2):321-8. PubMed ID: 6346849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crossover comparison of captopril and propranolol as step 2 agents in hypertension.
    Oren A; Rotmensch HH; Vlasses PH; Riley LJ; Tadros SS; Koplin JR; Ferguson RK
    Am Heart J; 1985 Mar; 109(3 Pt 1):554-7. PubMed ID: 3883729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol.
    MacGregor GA; Markandu ND; Banks RA; Bayliss J; Roulston JE; Jones JC
    Br Med J (Clin Res Ed); 1982 Mar; 284(6317):693-6. PubMed ID: 6802291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine.
    MacGregor GA; Markandu ND; Smith SJ; Sagnella GA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S82-7. PubMed ID: 2580182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension.
    Aldigier JC; Plouin PF; Guyene TT; Thibonnier M; Corvol P; Menard J
    Am J Cardiol; 1982 Apr; 49(6):1447-52. PubMed ID: 7041584
    [No Abstract]   [Full Text] [Related]  

  • 14. Captopril in mild and severe hypertension.
    Walter NM; Whitworth JA; Kincaid-Smith P
    Clin Exp Pharmacol Physiol; 1980; 7(5):477-80. PubMed ID: 7004679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of sympathetic nervous system activity in the blood pressure response to long-term captopril therapy in severely hypertensive patients.
    Weinberger MH
    Am J Cardiol; 1982 Apr; 49(6):1542-3. PubMed ID: 7041594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of captopril on renal hemodynamics in hypertensive patients.
    Duchin KL; Willard DA
    J Clin Pharmacol; 1984; 24(8-9):351-9. PubMed ID: 6384279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system.
    Riegger GA; Steilner H; Hayduk K; Liebau G
    Am J Cardiol; 1982 Apr; 49(6):1555-7. PubMed ID: 6803566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA; Drayer JI; Priest RT; Chen TC
    Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin- and non-renin-mediated antihypertensive actions of converting enzyme inhibitors.
    Zusman RM
    Kidney Int; 1984 Jun; 25(6):969-83. PubMed ID: 6088887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.